EBQ:San Francisco Syncope Rule: Difference between revisions
Ostermayer (talk | contribs) |
Ostermayer (talk | contribs) No edit summary |
||
| Line 13: | Line 13: | ||
| fulltexturl= http://www.sciencedirect.com.journals.labiomed.org/science/article/pii/S0196064405019591 | | fulltexturl= http://www.sciencedirect.com.journals.labiomed.org/science/article/pii/S0196064405019591 | ||
| pdfurl=http://theddx.org/papers/San_Francisco_syncope.pdf | | pdfurl=http://theddx.org/papers/San_Francisco_syncope.pdf | ||
| status=Under Review | |||
}} | }} | ||
==Clinical Question== | ==Clinical Question== | ||
Revision as of 16:48, 29 April 2014
Under Review Journal Club Article
Quinn J. et al.. "Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes". Ann Emerg Med. 2006. 31(26):2992-6.
PubMed Full text PDF
PubMed Full text PDF
Clinical Question
Conclusion
Major Points
- Criteria (CHESS Pneumonic)[1]
- CHF History
- Hct < 30%
- ECG Abnormality
- SOB history
- SBP < 90mmHg at triage
Study Design
Population
Patient Demographics
Inclusion Criteria
Exclusion Criteria
Interventions
Outcomes
Primary Outcome
Secondary Outcomes
Subgroup analysis
Criticisms & Further Discussion
Funding
Sources
- ↑ Quinn J, McDermott D, Stiell I, Kohn M, Wells G. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med. 2006 May;47(5):448-54. PubMed PMID: 16631985.